story of the week
Veliparib With Carboplatin and Paclitaxel in BRCA-Mutated Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Veliparib With Carboplatin and Paclitaxel in BRCA-Mutated Advanced Breast Cancer (BROCADE3): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial
Lancet Oncol 2020 Aug 27;[EPub Ahead of Print], V Diéras, HS Han, B Kaufman, H Wildiers, M Friedlander, JP Ayoub, SL Puhalla, I Bondarenko, M Campone, EH Jakobsen, M Jalving, C Oprean, M Palácová, YH Park, Y Shparyk, E Yañez, N Khandelwal, MG Kundu, M Dudley, CK Ratajczak, D Maag, BK ArunFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.